

|
Drug Giant Eli Lilly and Company will pay the state $25 million to settle claims it marketed its anti-psychotic drug Zyprexa for unapproved uses and harmed patients.
|
|
Connecticut officials say Eli Lilly Co . has agreed to a $25 million settlement with the state over claims the drugmaker marketed its anti-psychotic drug Zyprexa for unapproved uses and harmed patients.
|
|
AstraZeneca PLC said Tuesday that a European Union panel has approved the use of Seroquel for preventing the recurrence of major depression, reversing a decision in May by Dutch authorities against licensing.
|
|
E-mail: h.gurling@ucl.ac.uk Received 21 May 2008; Revised 11 August 2008; Accepted 14 August 2008; Published online 2 December 2008.
|
|
It was a summer of ups and downs for January Schofield, the child diagnosed with schizophrenia who was the subject of a Los Angeles Times article on June 29.
|
|
Pfizer Inc. paid the National Alliance for the Mentally Ill hundreds of thousands of dollars and its former president thousands more, turning the organization into a "Trojan horse" for an illegal marketing scheme that helped boost the schizophrenia drug Geodon's sales by millions of dollars a year, according to a lawsuit unsealed this week.
|
|
Scientists have identified dozens of genes that work differently in the brains of people with schizophrenia, a finding that could narrow the search for new drugs to treat the condition, researchers said on Tuesday.
|
|
The pharmaceutical company Pfizer has reached a $33-million settlement with Oregon and 42 other states after being accused of illegally marketing a drug called Geodon.
|
|
Schizophrenia is a major public health problem. Affecting almost 1% of the world's population, it takes an enormous economic and social toll in addition to the distress, dysfunction, disability and mortality for those afflicted with this disease.
|
|
In June, I spoke with two health care hedge fund analysts who laid out the bull and bear case on Vanda Pharmaceuticals after the company surprised everyone by receiving regulatory approval for its schizophrenia drug Fanapt.
|